rfhg_187058.1

Basic information about the TSS

---

TSS ID: rfhg_187058.1 TSS ID(Version3): hg_158379.1 hg_158380.1 Species: human Chr: chr16		Start: 85011464 End: 85011541 Strand: -
Source datasets	FANTOM5|PRJNA401781|PRJNA548673|PRJNA615891|PRJNA4843412 |DRA013844
Protocol	CAGE|ReCappable-seq|SLIC_CAGE|NETCAGE
TSS cluster detected*	7

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2892358,EH38E1833779)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000313732.9:0 ENST00000344861.9:0 ENST00000564466.5:0 AK000286:0 BC018772:0 AK225768:0 GeneID: 55625 HGNC/MGI_ID: HGNC:18459 UniProt_ID: Q9NXF8 Nearer transcript ids and distances:

Gene_name: zinc finger DHHC-type palmitoyltransferase 7 Gene_symbol: ZDHHC7 Gene_synonyms: DHHC7 FLJ10792 FLJ20279 SERZ-B SERZ1 ZNF370 Gene_source: HGNC:18459

TATA-Box annotation

---

Distance to TSS:	33
Nearest PromoterID:	NM_017740
Entrez ID:	55625
Nearest Unigene:	Hs.461610
Nearest Refseq:	NM_017740
Nearest Ensembl:	ENSG00000153786
Gene Name:	zinc finger DHHC-type palmitoyltransferase 7
Gene Alias:	DHHC7|SERZ-B|SERZ1|ZNF370
Gene Type:	protein-coding
CpG%:	0.077922
GC%:	0.692308
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZDHHC7 p2@ZDHHC7
Sample		p1@ZDHHC7	p2@ZDHHC7
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.40	2.34
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	23.87	3.44
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.38	3.67
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.84	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.95	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.61	2.91
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	23.53	3.27
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.01	4.60
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.30	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.71	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	22.23	4.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.92	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	54.16	8.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	46.76	7.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	51.38	7.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	45.52	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	44.99	8.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	40.49	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	47.45	9.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.28	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	48.38	9.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.47	7.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	42.27	7.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	39.80	5.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	41.28	8.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	38.93	8.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	46.15	8.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	45.26	8.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	40.38	6.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	42.16	11.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	32.66	7.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.32	7.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	37.56	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.01	7.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	31.41	7.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	41.77	6.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	36.18	6.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.03	6.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	32.68	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.21	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.05	4.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.94	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.80	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.99	7.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	28.71	6.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	27.22	7.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.27	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.63	5.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	31.12	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.13	9.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.34	5.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	23.57	7.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.81	10.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.88	5.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.32	7.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.01	8.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	23.45	5.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.43	6.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.84	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	28.60	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	8.76	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.63	7.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	24.37	9.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	26.98	7.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	34.61	11.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	39.67	6.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.09	7.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.88	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	32.48	9.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	39.44	10.40
Adipocyte - breast, donor1	11376-118A8	42.45	4.59
Adipocyte - breast, donor2	11327-117E4	35.61	6.90
Adipocyte - omental, donor1	11473-119C6	37.53	3.69
Adipocyte - omental, donor2	11474-119C7	41.86	10.46
Adipocyte - omental, donor3	11475-119C8	32.49	8.04
Adipocyte - perirenal, donor1	11476-119C9	26.16	10.21
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	5.42
Adipocyte - subcutaneous, donor3	11408-118E4	27.63	7.47
Adipocyte differentiation, day04, donor1	13019-139D4	40.48	6.45
Adipocyte differentiation, day04, donor2	13022-139D7	38.61	7.72
Adipocyte differentiation, day04, donor3	13025-139E1	35.68	7.53
Adipocyte differentiation, day04, donor4	13028-139E4	48.20	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	31.61	6.76
Adipocyte differentiation, day08, donor2	13023-139D8	43.89	8.71
Adipocyte differentiation, day08, donor3	13026-139E2	43.19	5.87
Adipocyte differentiation, day08, donor4	13029-139E5	38.39	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	25.79	9.98
Adipocyte differentiation, day12, donor2	13024-139D9	43.45	9.54
Adipocyte differentiation, day12, donor3	13027-139E3	32.40	6.22
Adipocyte differentiation, day12, donor4	13030-139E6	37.15	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	41.33	7.73
Alveolar Epithelial Cells, donor2	11590-120G6	38.73	10.76
Alveolar Epithelial Cells, donor3	11671-122G6	38.34	10.78
Amniotic Epithelial Cells, donor1	11533-120A3	75.56	12.95
Amniotic Epithelial Cells, donor2	11613-122A2	68.61	21.76
Amniotic Epithelial Cells, donor3	11694-123A2	99.44	12.33
Anulus Pulposus Cell, donor1	11248-116E6	47.03	10.98
Anulus Pulposus Cell, donor2	11463-119B5	56.57	13.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.32	13.93
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.67	9.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.51	8.37
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	36.96	11.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.82	5.52
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	28.16	7.28
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.16	10.69
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	21.47	6.40
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.87	5.81
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	30.09	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.75	6.92
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	29.56	9.05
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.75	5.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.56	7.18
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	34.48	6.68
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	8.78
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.23	6.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	37.22	7.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	14.16
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.19	6.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	25.17
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	6.31
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	23.91	7.59
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	9.69
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.80	6.84
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	24.16	8.76
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	26.33	6.71
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	23.46	10.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.94	8.68
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	30.68	6.42
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.21	7.02
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.48	7.53
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	29.70	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	8.65
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.88	6.88
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.78	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.40	6.47
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	22.02	5.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	30.16	5.22
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.95	5.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	24.07	6.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	37.06	11.58
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.80	7.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	36.70	5.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	5.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	19.31	5.98
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	27.20	6.61
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.19	6.61
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.54	9.79
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	7.17
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	21.29	5.54
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.74	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.30	7.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.63	5.82
Astrocyte - cerebellum, donor1	11500-119F6	31.20	14.25
Astrocyte - cerebellum, donor2	11580-120F5	43.13	15.23
Astrocyte - cerebellum, donor3	11661-122F5	32.09	9.86
Astrocyte - cerebral cortex, donor1	11235-116D2	29.98	8.02
Astrocyte - cerebral cortex, donor2	11316-117D2	31.71	10.84
Astrocyte - cerebral cortex, donor3	11392-118C6	30.28	7.16
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	21.79	7.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	23.18	7.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	20.26	5.69
Basophils, donor1	12241-129G9	115.60	8.63
Basophils, donor2	12242-129H1	149.01	4.69
Basophils, donor3	12243-129H2	131.56	4.56
Bronchial Epithelial Cell, donor1	11511-119G8	31.05	9.49
Bronchial Epithelial Cell, donor2	11591-120G7	30.63	9.60
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	14.35
Bronchial Epithelial Cell, donor4	11453-119A4	45.82	6.28
Bronchial Epithelial Cell, donor5	11457-119A8	32.86	5.61
Bronchial Epithelial Cell, donor6	11461-119B3	30.86	5.76
Bronchial Epithelial Cell, donor7	11769-123I5	30.05	5.94
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.52	7.01
Burkitt's lymphoma cell line:RAJI	10476-106I8	34.47	8.62
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	30.06	7.67
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	10.34
CD14+ Monocytes, donor1	11224-116B9	102.00	7.89
CD14+ Monocytes, donor2	11305-117B9	142.73	12.25
CD14+ Monocytes, donor3	11381-118B4	150.16	11.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	118.60	15.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	138.36	18.95
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	141.69	18.74
CD14+ monocytes - mock treated, donor1	11863-125A9	150.62	7.66
CD14+ monocytes - mock treated, donor2	11873-125C1	107.12	9.35
CD14+ monocytes - mock treated, donor3	11883-125D2	152.56	14.45
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	62.94	4.52
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	57.41	3.04
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	47.11	3.22
CD14+ monocytes - treated with BCG, donor1	11860-125A6	25.65	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	33.47	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	33.95	2.83
CD14+ monocytes - treated with Candida, donor1	11868-125B5	49.87	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	71.81	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	69.89	6.66
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	84.94	4.46
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	60.66	6.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	49.55	5.20
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	46.67	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	35.29	2.49
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	43.65	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	65.90	5.11
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	58.79	5.06
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	69.01	8.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	21.13	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	19.37	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	30.71	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	36.97	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	40.88	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	45.27	3.02
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	27.03	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.24	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	18.56	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	117.92	10.46
CD14+CD16+ Monocytes, donor2	11801-124D1	100.48	8.78
CD14+CD16+ Monocytes, donor3	11912-125G4	118.92	9.31
CD14+CD16- Monocytes, donor1	11788-124B6	250.56	14.95
CD14+CD16- Monocytes, donor2	11799-124C8	160.67	14.32
CD14+CD16- Monocytes, donor3	11910-125G2	237.69	21.85
CD14-CD16+ Monocytes, donor1	11790-124B8	117.89	7.40
CD14-CD16+ Monocytes, donor2	11800-124C9	92.22	12.52
CD14-CD16+ Monocytes, donor3	11911-125G3	109.06	12.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	38.64	14.92
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	35.21	8.28
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	34.11	8.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	31.09	8.04
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.18	9.83
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.81	10.20
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	1.32
CD19+ B Cells, donor1	11544-120B5	32.05	7.40
CD19+ B Cells, donor2	11624-122B4	31.19	2.90
CD19+ B Cells, donor3	11705-123B4	28.27	3.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	38.79	12.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	40.35	13.98
CD34+ Progenitors, donor1	11545-120B6	39.16	4.02
CD34+ Progenitors, donor2	11625-122B5	26.40	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	32.31	11.27
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	33.82	10.37
CD4+ T Cells, donor1	11225-116C1	64.98	7.50
CD4+ T Cells, donor2	11306-117C1	87.57	8.57
CD4+ T Cells, donor3	11382-118B5	69.23	8.84
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	31.90	4.85
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	32.12	11.68
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	38.52	12.94
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	35.56	7.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	26.69	7.02
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	19.78
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	22.11	4.91
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	37.28	12.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	32.56	13.70
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	32.73	4.93
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	31.10	10.13
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	27.28	11.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	26.99	6.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	33.24	11.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.41	10.36
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	51.12	8.70
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	55.74	13.93
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	17.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	30.22	5.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	31.84	8.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	35.73	11.77
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	48.54	5.56
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	38.56	6.93
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	32.69	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.45	13.36
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	44.31	11.08
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	33.50	15.35
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	45.14	18.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	44.42	17.91
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	10.78
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	59.81	11.46
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	51.24	22.16
CD8+ T Cells, donor1	11226-116C2	123.43	12.11
CD8+ T Cells, donor2	11307-117C2	139.29	12.01
CD8+ T Cells, donor3	11383-118B6	105.29	11.61
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	14.22	7.80
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.34	5.75
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.23	6.57
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.41	8.11
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.24	9.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.78	6.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.52	6.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.27	7.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	14.31	7.27
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.51	8.45
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.69	6.39
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.32	8.26
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	9.19	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.57	7.29
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	5.97
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.25	8.28
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	16.40	6.62
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	18.15	8.96
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.09	7.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.99	9.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.79	7.69
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	12.24	9.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.40	5.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	5.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.06	8.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.28	6.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	17.03	9.02
Cardiac Myocyte, donor1	11525-119I4	9.14	5.48
Cardiac Myocyte, donor2	11605-120I3	18.28	4.45
Cardiac Myocyte, donor3	11686-122I3	19.47	3.68
Chondrocyte - de diff, donor1	11261-116G1	43.33	10.05
Chondrocyte - de diff, donor2	11338-117F6	35.18	8.88
Chondrocyte - de diff, donor3	11410-118E6	40.39	7.62
Chondrocyte - re diff, donor2	11339-117F7	29.54	5.37
Chondrocyte - re diff, donor3	11411-118E7	30.33	7.68
Ciliary Epithelial Cells, donor1	11242-116D9	31.56	8.72
Ciliary Epithelial Cells, donor2	11323-117D9	32.06	8.12
Ciliary Epithelial Cells, donor3	11399-118D4	31.59	8.94
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	44.66	12.93
Corneal Epithelial Cells, donor1	11526-119I5	22.40	6.59
Corneal Epithelial Cells, donor2	11606-120I4	18.20	9.10
Corneal Epithelial Cells, donor3	11687-122I4	32.47	5.62
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	92.12	14.86
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	82.01	17.35
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	75.92	20.70
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	64.47	12.20
Dendritic Cells - plasmacytoid, donor1	11228-116C4	93.27	15.72
Dendritic Cells - plasmacytoid, donor2	11309-117C4	54.19	12.40
Dendritic Cells - plasmacytoid, donor3	11385-118B8	67.27	15.97
Endothelial Cells - Aortic, donor0	11207-116A1	21.85	6.17
Endothelial Cells - Aortic, donor1	11263-116G3	22.30	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	33.65	7.64
Endothelial Cells - Aortic, donor3	11412-118E8	37.35	8.26
Endothelial Cells - Artery, donor1	11264-116G4	29.67	5.53
Endothelial Cells - Artery, donor2	11341-117F9	33.64	8.94
Endothelial Cells - Artery, donor3	11413-118E9	26.30	5.79
Endothelial Cells - Lymphatic, donor1	11236-116D3	29.04	7.31
Endothelial Cells - Lymphatic, donor2	11317-117D3	38.95	9.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	30.45	8.46
Endothelial Cells - Microvascular, donor1	11265-116G5	14.56	6.83
Endothelial Cells - Microvascular, donor2	11342-117G1	21.87	6.25
Endothelial Cells - Microvascular, donor3	11414-118F1	18.15	5.10
Endothelial Cells - Thoracic, donor1	11266-116G6	30.41	9.60
Endothelial Cells - Thoracic, donor2	11343-117G2	28.30	7.34
Endothelial Cells - Umbilical vein, donor1	11243-116E1	34.54	5.84
Endothelial Cells - Umbilical vein, donor2	11324-117E1	43.67	10.21
Endothelial Cells - Umbilical vein, donor3	11400-118D5	40.18	11.72
Endothelial Cells - Vein, donor1	11267-116G7	25.03	4.55
Endothelial Cells - Vein, donor2	11344-117G3	21.65	4.89
Endothelial Cells - Vein, donor3	11416-118F3	31.87	1.41
Eosinophils, donor1	12244-129H3	76.23	0.00
Eosinophils, donor2	12245-129H4	234.34	18.15
Eosinophils, donor3	12246-129H5	174.77	10.70
Esophageal Epithelial Cells, donor1	11507-119G4	23.46	6.35
Esophageal Epithelial Cells, donor2	11587-120G3	33.28	8.32
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	32.54
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	48.44	6.57
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	30.66	8.54
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.08	8.99
Fibroblast - Aortic Adventitial, donor1	11245-116E3	30.44	6.79
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	48.17	8.19
Fibroblast - Aortic Adventitial, donor2	11326-117E3	37.13	7.38
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.33	16.07
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.85	8.97
Fibroblast - Cardiac, donor1	11268-116G8	22.23	7.71
Fibroblast - Cardiac, donor2	11345-117G4	25.01	7.58
Fibroblast - Cardiac, donor3	11417-118F4	22.71	2.84
Fibroblast - Cardiac, donor4	11452-119A3	31.52	7.88
Fibroblast - Cardiac, donor5	11456-119A7	33.63	5.20
Fibroblast - Cardiac, donor6	11460-119B2	34.41	8.49
Fibroblast - Choroid Plexus, donor1	11492-119E7	31.09	8.84
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.57	9.49
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	11.72
Fibroblast - Conjunctival, donor1	11531-120A1	57.89	18.91
Fibroblast - Conjunctival, donor3	11692-122I9	38.33	13.40
Fibroblast - Dermal, donor1	11269-116G9	36.16	11.97
Fibroblast - Dermal, donor2	11346-117G5	28.77	8.02
Fibroblast - Dermal, donor3	11418-118F5	34.69	9.07
Fibroblast - Dermal, donor4	11450-119A1	30.07	11.08
Fibroblast - Dermal, donor5	11454-119A5	32.80	15.70
Fibroblast - Dermal, donor6	11458-119A9	40.28	16.89
Fibroblast - Gingival, donor1	11237-116D4	37.90	7.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	66.55	17.03
Fibroblast - Gingival, donor2	11318-117D4	47.31	10.02
Fibroblast - Gingival, donor3	11394-118C8	46.41	8.90
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	9.35
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	44.76	7.75
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	62.67	11.69
Fibroblast - Gingival, donor6 (control)	11922-125H5	57.34	17.44
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	57.87	20.11
Fibroblast - Gingival, donor7 (control)	11924-125H7	68.44	14.33
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	60.68	13.77
Fibroblast - Gingival, donor8 (control)	11926-125H9	69.11	16.12
Fibroblast - Gingival, donor9 (control)	11927-125I1	63.68	19.66
Fibroblast - Lung, donor1	11270-116H1	24.47	8.16
Fibroblast - Lung, donor2	11347-117G6	32.83	11.94
Fibroblast - Lung, donor3	11419-118F6	48.33	13.51
Fibroblast - Lymphatic, donor1	11506-119G3	46.65	13.33
Fibroblast - Lymphatic, donor2	11586-120G2	55.95	19.58
Fibroblast - Lymphatic, donor3	11667-122G2	26.31	4.20
Fibroblast - Mammary, donor1	11540-120B1	65.36	19.89
Fibroblast - Mammary, donor2	11620-122A9	47.93	11.98
Fibroblast - Mammary, donor3	11701-123A9	83.39	11.91
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.59	9.50
Fibroblast - Periodontal Ligament, donor2	11319-117D5	57.49	16.99
Fibroblast - Periodontal Ligament, donor3	11395-118C9	46.82	7.65
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	57.63	14.50
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	77.49	9.18
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	59.84	9.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	24.76	3.98
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	99.16	19.71
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	54.12	15.37
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	29.65	6.72
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	64.89	14.29
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	31.97	6.39
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	35.67	6.90
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	55.66	14.14
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	38.21	10.90
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	51.37	19.49
Fibroblast - skin normal, donor1	11553-120C5	36.43	9.84
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	54.74	7.42
Fibroblast - skin normal, donor2	11561-120D4	33.76	6.93
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	55.91	13.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.51	6.63
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	43.93	11.11
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	53.86	12.15
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	33.13	7.03
Fibroblast - skin walker warburg, donor1	11554-120C6	35.76	8.43
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	22.11	6.74
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	28.76	6.97
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	39.18	5.72
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	31.49	6.25
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	35.77	7.15
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	34.45	18.37
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	37.01	16.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	49.92	20.82
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	96.52	42.47
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	54.57	26.94
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	55.87	16.25
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	92.78	39.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	64.58	21.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	34.49	16.36
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	33.63	13.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	34.97	14.04
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.92	17.19
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.11	10.04
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.36	11.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	33.95	7.52
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	39.25	9.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	32.39	10.96
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	46.12	10.05
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.43	9.46
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.95	11.29
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.29	10.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	38.31	9.48
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	28.16	10.35
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	41.50	9.49
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.11	9.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.20	9.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.66	12.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.60	10.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.85	8.98
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.37	8.66
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.59	11.64
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	38.52	10.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	40.12	9.70
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	30.50	12.18
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	37.28	7.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	42.33	9.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	29.47	10.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	31.64	10.12
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.10	10.03
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.91	9.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	36.23	10.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.15	7.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.85	11.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.56	11.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	35.34	9.03
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.39	8.29
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.64	12.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	46.27	10.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	34.65	11.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	38.68	23.80
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.41	8.84
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.68	10.89
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	39.39	10.93
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	34.24	11.15
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	33.59	15.25
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	48.08	20.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	43.81	11.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.14	11.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	50.27	17.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	47.02	34.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	42.16	11.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	12.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	52.16	10.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	41.66	11.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.71	11.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	42.51	13.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.99	16.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	50.33	12.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	42.94	14.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	34.65	13.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	31.32	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	38.37	18.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	42.03	12.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	42.35	13.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	36.04	15.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.65	13.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	35.37	8.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	36.83	11.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	54.84	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	47.77	19.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	61.96	13.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	14.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	57.57	20.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	15.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	48.83	18.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	36.69	8.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	49.34	16.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	53.12	18.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	39.09	15.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	53.10	17.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	48.32	18.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	42.98	8.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.45	8.25
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	9.13
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	32.85	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	31.48	10.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	42.18	13.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	34.25	10.44
Hep-2 cells mock treated, biol_rep1	11898-125E8	22.86	6.03
Hep-2 cells mock treated, biol_rep2	11899-125E9	23.13	10.30
Hep-2 cells mock treated, biol_rep3	11900-125F1	19.57	7.51
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.50	7.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.77	5.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	21.96	5.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	19.68	3.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.78	4.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	15.06	3.52
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	30.78	4.48
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	33.33	6.92
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	39.50	7.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	7.99
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.41	4.72
Hepatocyte, donor1	11523-119I2	12.11	8.47
Hepatocyte, donor2	11603-120I1	30.17	3.23
Hepatocyte, donor3	11684-122I1	15.95	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	34.59	12.40
Intestinal epithelial cells (polarized), donor1	11246-116E4	76.90	15.03
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.01	7.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	19.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	35.99	13.84
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	43.86	16.24
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	11.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	31.76	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	27.72	7.76
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.27	6.30
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	23.20	12.37
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	7.75
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	35.42	12.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	34.22	11.41
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.71	7.98
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	22.50	11.25
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	29.55	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	23.60	6.14
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	11.79	7.26
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	22.60	6.46
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	20.33	6.35
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	24.87	14.03
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	47.41
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	26.42	7.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	24.08	8.95
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	8.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	8.34
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	15.49
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	27.03	7.85
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	11.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	9.60
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	6.93
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	14.25
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	6.44
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	12.10
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	24.32	5.29
Keratinocyte - epidermal, donor1	11272-116H3	35.33	10.20
Keratinocyte - epidermal, donor2	11349-117G8	7.03	2.93
Keratinocyte - epidermal, donor3	11421-118F8	32.47	7.76
Keratinocyte - oral, donor1	11251-116E9	35.64	5.68
Keratocytes, donor1	11527-119I6	64.30	14.44
Keratocytes, donor2	11607-120I5	33.98	10.55
Keratocytes, donor3	11688-122I5	50.19	11.86
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	8.79
Lens Epithelial Cells, donor1	11529-119I8	35.60	6.47
Lens Epithelial Cells, donor2	11609-120I7	23.30	5.65
Lens Epithelial Cells, donor3	11690-122I7	25.13	4.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.62	5.57
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	14.51	3.63
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	19.20	5.35
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	6.45
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.28	3.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	15.74	5.71
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.59	6.98
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.10	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.92	6.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	3.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.60	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.96	5.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	15.68	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.31	2.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.40	5.63
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	18.48	5.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.72	3.74
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.78	5.67
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.46	6.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.82	3.22
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.92	5.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.00	5.82
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.20	2.69
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.14	5.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.33	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.35	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.59	7.97
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	16.51	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	11.85	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.12	5.20
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.71	4.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.89	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.09	3.72
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.47	6.66
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	13.84	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.22	4.40
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	3.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.04	3.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	16.52	4.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	16.36	3.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.60	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.00	3.42
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.68	3.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.01	3.27
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.36	4.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.28	5.82
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.60	2.31
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	13.13	4.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	65.71	15.86
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	62.90	20.71
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	40.08	18.56
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	72.78	23.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	46.42	14.77
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	63.51	16.81
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	51.53	18.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	38.06	19.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	56.10	15.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	56.42	16.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	55.37	13.96
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	64.36	19.10
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	72.41	20.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	58.93	14.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	56.64	15.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	73.86	19.36
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	62.97	18.68
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	63.49	17.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	77.31	24.54
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	66.86	27.72
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	58.93	14.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	63.06	20.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	54.61	21.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	56.90	12.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	55.30	18.53
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	45.92	16.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	56.91	20.86
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	50.52	15.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	35.69	14.97
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	58.71	17.27
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	43.59	11.89
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	32.00	16.41
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	54.23	21.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	49.55	17.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	37.35	19.42
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	60.94	17.84
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	57.72	19.81
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	52.23	12.84
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	57.97	19.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	66.97	19.31
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	52.61	11.38
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	55.34	13.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	60.65	17.18
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	57.24	19.53
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	63.71	17.04
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	39.54	13.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	57.12	16.92
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	62.82	18.41
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	81.41	18.17
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	78.95	13.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	67.09	16.77
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	67.75	19.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	73.91	16.09
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	62.19	16.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	75.73	18.93
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	61.01	22.71
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	69.21	22.29
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	69.93	17.81
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	72.13	18.68
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	74.82	20.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	73.24	20.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	71.55	11.92
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	62.49	15.43
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	80.51	21.27
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	67.77	19.71
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	67.98	19.48
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	68.66	20.66
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	51.19	17.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	75.62	17.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	71.27	19.62
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	51.40	20.56
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	62.43	16.48
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	69.83	18.66
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	45.40	27.01
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	62.22	18.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	77.10	29.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	50.51	18.16
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	54.50	13.73
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	52.46	14.88
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	48.44	17.54
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	55.29	16.26
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	56.20	13.38
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	49.19	24.59
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	59.40	22.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	55.98	20.19
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	41.79	27.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	60.98	25.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	59.82	15.34
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	39.94	19.15
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	64.59	19.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	52.25	16.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	36.47	24.53
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	78.99	8.31
Macrophage - monocyte derived, donor1	11232-116C8	93.22	10.26
Macrophage - monocyte derived, donor2	11313-117C8	59.46	13.21
Macrophage - monocyte derived, donor3	11389-118C3	92.81	14.42
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	17.52	3.19
Mallassez-derived cells, donor2	11929-125I3	33.12	13.47
Mallassez-derived cells, donor3	11930-125I4	22.65	4.17
Mammary Epithelial Cell, donor1	11273-116H4	21.62	3.69
Mammary Epithelial Cell, donor2	11350-117G9	19.11	6.37
Mammary Epithelial Cell, donor3	11422-118F9	24.69	5.24
Mast cell - stimulated, donor1	11487-119E2	17.63	2.03
Mast cell, donor1	11563-120D6	32.98	4.43
Mast cell, donor2	11565-120D8	25.56	8.32
Mast cell, donor3	11566-120D9	20.04	8.33
Mast cell, donor4	11567-120E1	26.42	8.16
Mast cell, expanded and stimulated, donor5	11940-126A5	34.82	10.09
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	8.17
Mast cell, expanded, donor5	11939-126A4	35.45	12.16
Mast cell, expanded, donor8	11941-126A6	40.50	14.56
Melanocyte - dark, donor1	11502-119F8	19.30	3.88
Melanocyte - dark, donor2	11582-120F7	23.88	5.19
Melanocyte - dark, donor3	11663-122F7	47.01	10.00
Melanocyte - light, donor1	11274-116H5	43.72	8.70
Melanocyte - light, donor2	11351-117H1	32.76	16.38
Melanocyte - light, donor3	11423-118G1	19.95	6.07
Melanocyte, donor1 (MC+1)	12641-134G4	34.05	9.27
Melanocyte, donor2 (MC+2)	12739-135I3	76.65	10.49
Melanocyte, donor3 (MC+3)	12837-137B2	57.05	10.71
Meningeal Cells, donor1	11493-119E8	47.39	16.00
Meningeal Cells, donor2	11573-120E7	47.98	12.76
Meningeal Cells, donor3	11654-122E7	36.43	9.37
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	37.36	7.98
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	33.01	7.75
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	19.71	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	10.05
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	39.81	7.41
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	57.80	8.54
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	43.51	9.45
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	37.99	9.50
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	46.85	15.14
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	40.03	12.60
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	23.79	5.20
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	44.34	9.47
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.93	4.75
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	62.12	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	21.62	4.96
Mesenchymal stem cells - hepatic, donor0	11218-116B3	32.21	5.32
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.22	7.98
Mesothelial Cells, donor1	11247-116E5	54.89	6.36
Mesothelial Cells, donor2	12156-128G5	27.53	7.01
Mesothelial Cells, donor3	11402-118D7	42.85	7.88
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	78.32	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	88.17	14.53
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	77.74	11.19
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	127.91	20.74
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	69.74	12.09
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	52.90	10.79
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	141.28	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	78.83	13.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	77.74	16.29
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	71.33	9.35
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	66.13	8.71
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	94.07	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	41.59	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	56.23	12.92
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	103.96	5.26
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	44.99	8.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	58.93	4.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	42.92	5.37
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	43.59	5.03
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	40.14	4.27
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	49.43	7.13
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	49.76	6.08
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.72	4.84
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	47.75	8.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	34.04	2.45
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	33.68	5.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	44.01	4.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.48	3.50
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	33.46	7.60
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.76	4.89
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	38.52	7.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	32.71	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.49	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	36.02	5.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	26.05	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.02	5.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.33	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	4.41
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	26.90	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	16.61	5.95
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	24.36	3.48
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	46.41	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.93	7.86
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	39.82	4.81
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.73	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	28.90	5.61
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	43.23	5.40
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	35.55	3.50
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	42.23	6.64
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	37.98	8.35
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	38.79	6.46
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	44.39	6.83
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	33.44	5.53
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	31.10	5.44
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	42.90	6.01
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	44.46	5.08
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	38.70	6.41
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	65.85	9.88
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	42.94	4.66
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	33.76	8.60
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	42.46	8.85
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	59.53	9.48
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	38.35	10.23
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	53.59	6.64
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	49.53	5.21
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	49.40	12.35
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	64.59	11.24
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	70.89	9.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	58.96	14.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	64.04	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	58.81	10.69
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	97.26	12.16
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	96.78	13.68
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	161.31	20.56
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	167.64	20.49
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	79.61	13.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	89.76	14.12
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	65.71	8.82
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	106.83	10.31
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	107.00	10.63
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	98.00	12.44
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	36.88	8.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	87.86	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	70.41	11.38
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	20.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	49.84	7.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	137.04	28.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	163.14	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.67	11.42
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	42.33	5.23
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.05	14.02
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	43.82	18.36
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	28.90	8.18
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	44.68	22.34
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	32.64	14.96
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	44.36	11.72
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	49.51	12.78
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	45.94	13.78
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	41.21	10.72
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	55.10	11.42
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.63	9.20
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	46.24	12.24
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	38.70	13.06
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	46.84	11.66
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	57.29	21.22
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	57.03	19.81
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	16.08	5.58
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.49	14.47
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	44.80	13.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	52.74	11.95
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	57.46	14.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	52.06	13.82
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.73	6.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	49.68	10.92
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	39.80	9.74
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.48	11.39
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	57.09	12.88
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	59.98	14.99
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	49.14	6.31
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	32.14	11.90
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	53.86	21.36
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	48.05	14.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	47.58	13.69
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	37.48	6.54
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	47.49	13.57
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	48.50	21.17
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	51.19	18.62
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	58.04	8.93
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	48.62	18.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	56.25	11.49
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	40.67	12.38
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	48.11	10.16
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	73.16	10.36
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	37.14	15.74
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	36.32	16.34
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	47.47	18.20
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	13.60
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00
Myoblast, donor1	11241-116D8	34.54	7.70
Myoblast, donor2	11322-117D8	38.74	10.55
Myoblast, donor3	11398-118D3	31.28	7.57
NK T cell leukemia cell line:KHYG-1	10777-110G3	26.56	5.69
Natural Killer Cells, donor1	11230-116C6	111.94	8.92
Natural Killer Cells, donor2	11311-117C6	114.89	9.65
Natural Killer Cells, donor3	11387-118C1	104.73	11.96
Neural stem cells, donor1	11275-116H6	41.74	17.78
Neural stem cells, donor2	11352-117H2	30.81	9.63
Neurons, donor1	11494-119E9	19.34	9.10
Neurons, donor2	11574-120E8	24.88	11.45
Neurons, donor3	11655-122E8	36.18	15.62
Neutrophils, donor1	11233-116C9	128.99	9.28
Neutrophils, donor2	11314-117C9	194.22	17.39
Neutrophils, donor3	11390-118C4	283.43	8.55
Nucleus Pulposus Cell, donor1	11252-116F1	44.53	9.14
Nucleus Pulposus Cell, donor2	11409-118E5	50.47	13.02
Nucleus Pulposus Cell, donor3	11462-119B4	47.53	10.83
Olfactory epithelial cells, donor1	11933-125I7	65.66	11.70
Olfactory epithelial cells, donor2	11934-125I8	74.11	16.94
Olfactory epithelial cells, donor3	11935-125I9	84.22	12.26
Olfactory epithelial cells, donor4	11936-126A1	76.85	13.83
Oligodendrocyte - precursors, donor1	11496-119F2	56.57	10.23
Osteoblast - differentiated, donor1	11276-116H7	42.54	10.63
Osteoblast - differentiated, donor2	11353-117H3	34.29	13.72
Osteoblast - differentiated, donor3	11425-118G3	29.17	5.59
Osteoblast, donor1	11277-116H8	31.66	9.38
Osteoblast, donor2	11354-117H4	54.08	11.94
Osteoblast, donor3	11426-118G4	50.12	11.73
Pancreatic stromal cells, donor1	11249-116E7	45.40	8.93
Pericytes, donor1	11491-119E6	27.59	12.02
Pericytes, donor2	11571-120E5	25.58	11.77
Pericytes, donor3	11652-122E5	47.81	9.97
Perineurial Cells, donor1	11499-119F5	31.87	7.23
Perineurial Cells, donor2	11579-120F4	26.04	4.14
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	140.25	14.66
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	164.06	14.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	123.46	13.20
Placental Epithelial Cells, donor1	11278-116H9	39.94	11.00
Placental Epithelial Cells, donor2	11355-117H5	31.05	15.52
Placental Epithelial Cells, donor3	11427-118G5	63.61	8.44
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	29.11	6.96
Preadipocyte - breast, donor1	11467-119B9	31.14	6.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	29.24	5.22
Preadipocyte - breast, donor2	11328-117E5	36.02	6.98
Preadipocyte - omental, donor1	11468-119C1	42.94	3.62
Preadipocyte - omental, donor2	11329-117E6	41.46	12.22
Preadipocyte - omental, donor3	11403-118D8	40.54	9.17
Preadipocyte - perirenal, donor1	11469-119C2	35.43	11.81
Preadipocyte - subcutaneous, donor1	11279-116I1	25.80	7.68
Preadipocyte - subcutaneous, donor2	11356-117H6	44.80	8.85
Preadipocyte - subcutaneous, donor3	11428-118G6	35.59	8.34
Preadipocyte - visceral, donor1	11280-116I2	38.75	6.24
Preadipocyte - visceral, donor2	11357-117H7	40.96	6.44
Preadipocyte - visceral, donor3	11429-118G7	28.73	7.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	69.84	13.43
Prostate Epithelial Cells, donor2	11331-117E8	45.23	8.94
Prostate Epithelial Cells, donor3	11404-118D9	29.15	3.43
Prostate Stromal Cells, donor1	11254-116F3	40.09	7.29
Prostate Stromal Cells, donor2	11332-117E9	55.58	10.40
Prostate Stromal Cells, donor3	11405-118E1	70.07	6.99
Renal Cortical Epithelial Cells, donor1	11516-119H4	48.91	13.50
Renal Cortical Epithelial Cells, donor2	11596-120H3	39.37	10.40
Renal Epithelial Cells, donor1	11517-119H5	40.58	8.12
Renal Epithelial Cells, donor2	11597-120H4	53.35	21.34
Renal Epithelial Cells, donor3	11678-122H4	46.16	12.81
Renal Glomerular Endothelial Cells, donor1	11514-119H2	38.13	14.30
Renal Glomerular Endothelial Cells, donor2	11594-120H1	41.10	9.84
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.19	10.21
Renal Glomerular Endothelial Cells, donor4	11783-124B1	22.63	2.66
Renal Mesangial Cells, donor1	11518-119H6	40.94	10.78
Renal Mesangial Cells, donor2	11598-120H5	62.07	19.44
Renal Mesangial Cells, donor3	11679-122H5	45.77	8.60
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	71.40	7.78
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	55.24	7.59
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	81.00	18.13
Retinal Pigment Epithelial Cells, donor0	11215-116A9	37.34	10.63
Retinal Pigment Epithelial Cells, donor1	11528-119I7	37.80	8.81
Retinal Pigment Epithelial Cells, donor2	11608-120I6	33.96	13.38
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.09	8.03
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	37.69	5.35
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	5.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.31	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.26	6.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	18.85	6.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	26.91	6.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.67	6.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	24.56	6.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	28.55	8.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.44	8.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	25.47	9.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	26.47	7.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	31.36	9.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.24	9.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	26.08	6.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	26.77	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	20.07	7.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.62	5.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	30.25	7.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	23.09	8.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.06	7.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.35	8.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	23.39	7.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	26.63	6.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.07	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	25.16	9.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.21	8.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.80	9.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.59	10.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	31.35	8.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.00	10.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	22.19	7.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.99	7.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.36	9.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.88	8.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.35	6.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	29.11	7.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	24.93	7.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.90	8.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	30.04	8.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.64	7.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	22.93	6.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.19	7.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.57	7.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	31.43	4.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	37.49	7.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	22.79	5.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.59	9.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.78	6.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.97	6.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	54.44	11.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	41.98	9.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	22.00	4.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	40.26	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	47.03	7.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	24.80	7.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	37.14	6.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	33.65	7.81
Schwann Cells, donor1	11498-119F4	34.61	13.35
Schwann Cells, donor2	11578-120F3	20.41	6.80
Schwann Cells, donor3	11659-122F3	28.04	9.42
Sebocyte, donor1	11220-116B5	36.70	10.41
Sebocyte, donor2	11301-117B5	33.55	6.89
Sebocyte, donor3	11378-118B1	29.27	5.77
Sertoli Cells, donor1	11255-116F4	26.51	6.63
Sertoli Cells, donor2	11333-117F1	48.01	8.47
Skeletal Muscle Cells, donor1	11281-116I3	25.69	6.33
Skeletal Muscle Cells, donor2	11358-117H8	17.35	2.89
Skeletal Muscle Cells, donor3	11430-118G8	33.44	9.20
Skeletal Muscle Cells, donor4	11451-119A2	30.95	9.11
Skeletal Muscle Cells, donor5	11455-119A6	28.69	9.81
Skeletal Muscle Cells, donor6	11459-119B1	36.63	11.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	36.67	7.94
Skeletal Muscle Satellite Cells, donor2	11321-117D7	35.39	11.99
Skeletal Muscle Satellite Cells, donor3	11397-118D2	39.09	11.91
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	28.39	8.68
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	8.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.49	8.12
Skin - palm, donor1	10286-104F7	37.61	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	36.33	11.82
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	81.79	23.72
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.34	10.39
Small Airway Epithelial Cells, donor1	11256-116F5	29.75	4.17
Small Airway Epithelial Cells, donor2	11334-117F2	39.38	10.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	80.14	12.26
Small Airway Epithelial Cells, donor3	11406-118E2	40.40	9.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.14	8.95
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	40.24	17.79
Smooth Muscle Cells - Aortic, donor0	11210-116A4	33.51	8.82
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.09	2.87
Smooth Muscle Cells - Aortic, donor2	11360-117I1	31.11	3.94
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.86	15.45
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	5.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	20.09	4.39
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	31.47	7.31
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.14	7.30
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	23.44	6.84
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	43.41	7.38
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	40.57	8.11
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	51.24	12.53
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	43.84	10.96
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.53	5.05
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	25.75	6.68
Smooth Muscle Cells - Colonic, donor1	11239-116D6	35.69	7.23
Smooth Muscle Cells - Colonic, donor2	11320-117D6	37.24	13.13
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.78	9.97
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	29.54	5.26
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	36.65	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.67	8.07
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	43.70	11.27
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.59	11.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	40.96	11.78
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	47.33	9.33
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	36.23	8.45
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	38.41	8.74
Smooth Muscle Cells - Prostate, donor1	11257-116F6	45.14	10.65
Smooth Muscle Cells - Prostate, donor2	11335-117F3	45.45	10.27
Smooth Muscle Cells - Prostate, donor3	11465-119B7	53.27	8.88
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	29.55	6.78
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	35.26	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	9.05
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.93	8.37
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	32.31	11.61
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	31.65	6.89
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	40.41	14.45
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	49.57	10.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	71.01	13.08
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.46	5.47
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.42	7.39
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	31.21	5.26
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	31.86	9.50
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	38.37	7.37
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	34.76	6.19
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	24.47	5.14
Smooth Muscle Cells - Uterine, donor1	11258-116F7	38.44	9.72
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.89	7.02
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	65.50	9.72
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	44.43	7.93
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	31.24	7.44
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	80.13	10.06
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	47.70	5.39
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	35.05	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	46.73	10.67
Smooth muscle cells - airway, control, donor2	11967-126D5	57.50	15.17
Smooth muscle cells - airway, control, donor3	11968-126D6	67.30	10.03
Smooth muscle cells - airway, control, donor4	11969-126D7	56.84	9.17
Synoviocyte, donor1	11291-117A4	43.43	4.88
Synoviocyte, donor2	11368-117I9	46.26	4.53
Synoviocyte, donor3	11440-118H9	70.60	6.26
Trabecular Meshwork Cells, donor1	11532-120A2	61.82	15.72
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	36.82	6.25
Tracheal Epithelial Cells, donor1	11292-117A5	23.66	5.23
Tracheal Epithelial Cells, donor2	11369-118A1	22.03	3.87
Tracheal Epithelial Cells, donor3	11441-118I1	22.91	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	37.28	6.03
Urethra, donor2	10319-105A4	57.55	10.79
Urothelial Cells, donor1	11520-119H8	22.05	6.91
Urothelial Cells, donor2	11600-120H7	26.04	2.80
Urothelial Cells, donor3	11681-122H7	30.48	5.50
Urothelial cells, donor0	11216-116B1	31.21	6.24
Whole blood (ribopure), donor090309, donation1	12179-129A1	80.08	17.80
Whole blood (ribopure), donor090309, donation2	12180-129A2	88.64	17.16
Whole blood (ribopure), donor090309, donation3	12181-129A3	94.46	13.01
Whole blood (ribopure), donor090325, donation1	12176-128I7	65.08	14.12
Whole blood (ribopure), donor090325, donation2	12177-128I8	73.21	13.94
Whole blood (ribopure), donor090612, donation1	12182-129A4	66.64	12.49
Whole blood (ribopure), donor090612, donation2	12183-129A5	55.07	19.27
Whole blood (ribopure), donor090612, donation3	12184-129A6	77.60	8.22
Wilms' tumor cell line:G-401	10809-111A8	38.00	4.81
Wilms' tumor cell line:HFWT	10597-108E3	28.16	9.68
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	38.55	13.41
achilles tendon, donor2	10292-104G4	39.26	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	23.97	6.63
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	22.52	11.84
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	24.10	7.60
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	38.37	7.62
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	32.04	11.24
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	26.86	5.29
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	29.94	6.26
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.47	7.93
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	27.77	17.15
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	55.91	16.31
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	22.63	7.91
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	44.85	10.92
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	38.58	12.69
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	37.70	15.20
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	47.41	15.34
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	29.61	8.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	31.92	15.96
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	23.90	7.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	37.31	10.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	32.01	10.83
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	24.06	5.79
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	21.68	8.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	14.87	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.56	4.52
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	38.38	13.96
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	22.49
adenocarcinoma cell line:IM95m	10796-110I4	64.06	18.84
adipose tissue, adult, pool1	10010-101C1	37.54	6.52
adipose, donor1	10184-103D4	35.18	12.31
adipose, donor2	10185-103D5	54.74	28.39
adipose, donor3	10186-103D6	48.20	19.06
adipose, donor4	10187-103D7	37.27	12.13
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	41.19	25.25
adrenal gland, adult, pool1	10081-102A9	65.48	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.00	2.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	50.38	7.50
amniotic membrane cells, donor1	12235-129G3	72.34	16.69
amniotic membrane cells, donor2	12236-129G4	61.53	14.20
amniotic membrane cells, donor3	12237-129G5	55.68	11.19
amygdala - adult, donor10196	10167-103B5	28.46	11.86
amygdala, adult, donor10252	10151-102I7	43.19	9.73
amygdala, newborn, donor10223	10360-105E9	22.92	13.56
anaplastic carcinoma cell line:8305C	10428-106D5	60.48	11.33
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	24.93	5.52
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.45	13.36
aorta, adult, pool1	10052-101G7	43.93	10.40
appendix, adult	10189-103D9	54.72	19.41
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	23.39	8.60
artery, adult	10190-103E1	76.09	12.23
astrocytoma cell line:TM-31	10425-106D2	42.45	14.63
b cell line:RPMI1788	10427-106D4	20.67	5.50
basal cell carcinoma cell line:TE 354.T	10702-109G9	48.55	5.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	24.91	5.26
bile duct carcinoma cell line:TFK-1	10496-107C1	35.15	4.35
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	39.15	2.24
bladder, adult, pool1	10011-101C2	38.89	7.93
blood, adult, pool1	10053-101G8	68.65	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	29.12	4.28
bone marrow, adult	10192-103E3	41.84	15.52
brain, adult, donor1	10084-102B3	38.95	21.53
brain, adult, pool1	10012-101C3	20.16	9.58
brain, fetal, pool1	10085-102B4	64.11	10.69
breast carcinoma cell line:MCF7	10482-107A5	119.26	18.50
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.20	7.86
breast, adult, donor1	10080-102A8	71.97	5.05
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	90.83	14.86
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	89.67	21.03
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	23.25	12.89
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	34.38	22.03
carcinoid cell line:NCI-H1770	10703-109H1	43.73	13.63
carcinoid cell line:NCI-H727	10735-110B6	30.08	9.52
carcinoid cell line:SK-PN-DW	10719-109I8	18.06	5.39
carcinosarcoma cell line:JHUCS-1	10642-109A3	37.26	12.51
caudate nucleus - adult, donor10196	10177-103C6	26.48	1.15
caudate nucleus, adult, donor10252	10164-103B2	32.63	4.69
caudate nucleus, adult, donor10258	10379-105H1	26.74	25.22
caudate nucleus, newborn, donor10223	10354-105E3	29.30	15.38
cerebellum - adult, donor10196	10173-103C2	43.70	20.39
cerebellum, adult, donor10252	10166-103B4	60.42	11.32
cerebellum, adult, pool1	10083-102B2	41.05	14.49
cerebellum, newborn, donor10223	10357-105E6	45.67	17.44
cerebral meninges, adult	10188-103D8	20.93	8.32
cerebrospinal fluid, donor2	10294-104G6	15.35	7.31
cervical cancer cell line:D98-AH2	10552-107I3	37.67	9.63
cervical cancer cell line:ME-180	10553-107I4	51.87	8.12
cervix, adult, pool1	10013-101C4	48.51	12.49
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	36.23	8.08
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	6.53
choriocarcinoma cell line:BeWo	10423-106C9	43.37	7.33
choriocarcinoma cell line:SCH	10785-110H2	64.93	21.19
choriocarcinoma cell line:T3M-3	10618-108G6	30.36	18.74
chorionic membrane cells, donor1	12238-129G6	68.10	12.25
chorionic membrane cells, donor2	12239-129G7	56.58	9.94
chorionic membrane cells, donor3	12240-129G8	71.98	11.54
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	14.14	10.10
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	28.43	6.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	30.62	8.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	34.92	12.33
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	35.07	14.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	38.08	12.22
chronic myelogenous leukemia cell line:K562	10454-106G4	55.06	20.32
chronic myelogenous leukemia cell line:KU812	10409-106B4	26.32	6.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	190.87	35.43
clear cell carcinoma cell line:TEN	10636-108I6	67.49	9.89
colon carcinoma cell line:CACO-2	10513-107D9	71.02	16.29
colon carcinoma cell line:COLO-320	10420-106C6	55.49	14.44
colon, adult, donor1	10082-102B1	127.33	29.75
colon, adult, pool1	10014-101C5	50.53	10.93
colon, fetal, donor1	10070-101I7	78.48	11.12
common myeloid progenitor CMP, donor1	12130-128D6	110.00	45.84
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	17.85	6.37
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.94	6.19
cord blood derived cell line:COBL-a untreated	10449-106F8	18.61	5.50
corpus callosum, adult, pool1	10042-101F6	36.60	12.71
cruciate ligament, donor2	10295-104G7	42.95	9.73
diaphragm, fetal, donor1	10069-101I6	50.56	14.45
diencephalon, adult	10193-103E4	22.08	8.64
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	20.21	7.35
ductal cell carcinoma cell line:KLM-1	10438-106E6	55.39	20.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	32.74	11.55
ductus deferens, adult	10196-103E7	29.90	7.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	51.85	11.52
duodenum, fetal, donor1, tech_rep2	10071-101I8	40.46	10.30
dura mater, adult, donor1	10041-101F5	55.83	15.77
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	26.87	4.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.98	8.17
embryonic pancreas cell line:1B2C6	10604-108F1	46.86	12.95
embryonic pancreas cell line:1C3D3	10605-108F2	48.43	13.62
embryonic pancreas cell line:1C3IKEI	10606-108F3	34.27	12.35
embryonic pancreas cell line:2C6	10603-108E9	39.40	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	23.13	5.03
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	52.92	15.77
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	51.14	9.65
epidermoid carcinoma cell line:A431	10426-106D3	90.71	10.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	93.82	15.40
epididymis, adult	10197-103E8	33.49	11.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	34.77	11.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	19.27	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	32.11	7.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	32.48	8.37
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.26	7.73
esophagus, adult, pool1	10015-101C6	31.43	8.07
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	186.85	17.41
eye - muscle inferior rectus, donor1	10272-104E2	43.46	16.90
eye - muscle lateral, donor2	10298-104H1	48.40	6.31
eye - muscle medial, donor2	10299-104H2	37.21	16.37
eye - muscle superior, donor2	10297-104G9	50.45	8.03
eye - vitreous humor, donor1	10268-104D7	21.86	5.83
eye, fetal, donor1	10054-101G9	34.58	11.44
fibrosarcoma cell line:HT-1080	10758-110E2	49.37	12.95
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	30.39	19.47
frontal lobe, adult, pool1	10040-101F4	30.77	10.51
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	36.03	9.01
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	71.50	15.09
gall bladder, adult	10198-103E9	54.08	11.11
gamma delta positive T cells, donor1	11937-126A2	55.30	11.27
gamma delta positive T cells, donor2	11938-126A3	57.14	16.06
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.82	4.22
gastric adenocarcinoma cell line:MKN45	10612-108F9	37.33	8.70
gastric cancer cell line:AZ521	10549-107H9	28.20	6.72
gastric cancer cell line:GSS	10560-108A2	4.58	16.47
gastrointestinal carcinoma cell line:ECC12	10615-108G3	21.02	8.00
giant cell carcinoma cell line:LU65	10487-107B1	28.80	10.79
giant cell carcinoma cell line:Lu99B	10433-106E1	47.17	4.90
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.45	3.99
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.00	10.45
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.83	9.27
glioblastoma cell line:T98G	10485-107A8	54.75	12.36
glioma cell line:GI-1	10413-106B8	46.57	8.49
globus pallidus - adult, donor10196	10175-103C4	34.26	8.02
globus pallidus, adult, donor10252	10161-103A8	42.47	8.30
globus pallidus, adult, donor10258	10367-105F7	20.54	10.95
globus pallidus, newborn, donor10223	10364-105F4	21.85	10.13
granulocyte macrophage progenitor, donor1	12131-128D7	146.83	44.05
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45
granulosa cell tumor cell line:KGN	10624-108H3	61.12	13.44
hIPS +CCl2, biol_rep1	14383-156B9	31.22	15.61
hIPS +CCl2, biol_rep2	14384-156C1	25.15	12.80
hIPS +CCl2, biol_rep3	14385-156C2	28.98	22.54
hIPS, biol_rep1	14380-156B6	20.12	24.43
hIPS, biol_rep2	14381-156B7	28.12	14.40
hIPS, biol_rep3	14382-156B8	16.55	12.14
hairy cell leukemia cell line:Mo	10712-109I1	18.10	12.64
heart - mitral valve, adult	10205-103F7	31.69	8.37
heart - pulmonic valve, adult	10206-103F8	42.36	12.29
heart - tricuspid valve, adult	10207-103F9	34.14	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	52.03	14.49
heart, adult, diseased, donor1	10051-101G6	54.08	11.07
heart, adult, pool1	10016-101C7	42.55	11.50
heart, fetal, pool1	10046-101G1	56.58	11.40
hepatic mesenchymal tumor cell line:LI90	10778-110G4	46.28	7.40
hepatoblastoma cell line:HuH-6	10633-108I3	33.30	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	66.85	5.52
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	66.27	7.16
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.57	6.57
hepatoma cell line:Li-7	10484-107A7	26.36	5.34
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	20.80	8.44
hippocampus - adult, donor10196	10169-103B7	22.71	11.36
hippocampus, adult, donor10252	10153-102I9	36.94	7.55
hippocampus, adult, donor10258	10374-105G5	19.92	18.42
hippocampus, newborn, donor10223	10363-105F3	27.85	15.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	34.18	22.58
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	47.71	17.48
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	37.58	17.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	89.09	39.47
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	95.54	40.28
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	79.34	36.06
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.96	22.19
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.73	23.05
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	45.04	21.27
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	29.84	10.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.54	14.79
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	28.95	9.43
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	41.47	14.24
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	13.76
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	12.22
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	110.92	39.71
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	113.38	37.94
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	56.97	30.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	56.14	23.93
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	59.57	25.92
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	46.67	25.37
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	44.09	12.41
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	36.58	11.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	35.27	12.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	51.17	12.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	48.50	17.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	31.03	6.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	73.23	16.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	89.00	21.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	66.27	19.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.13	17.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	49.81	12.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.28	11.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	35.28	9.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	44.68	10.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	32.26	7.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	48.78	14.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	32.53	14.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	44.39	13.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	86.18	25.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	40.71	11.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	44.88	15.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.98	15.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	37.37	11.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	32.37	8.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.71	7.54
immature langerhans cells, donor1	11904-125F5	31.24	8.96
immature langerhans cells, donor2	11905-125F6	47.53	5.54
insula, adult, pool1	10039-101F3	37.66	12.59
keratoacanthoma cell line:HKA-1	10791-110H8	90.07	13.98
kidney, adult, pool1	10017-101C8	41.15	9.01
kidney, fetal, pool1	10045-101F9	52.42	15.56
large cell lung carcinoma cell line:IA-LM	10509-107D5	75.84	12.78
large cell lung carcinoma cell line:NCI-H460	10839-111E2	23.64	6.22
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	52.66	8.44
left atrium, adult, donor1	10079-102A7	43.59	6.54
left ventricle, adult, donor1	10078-102A6	34.89	5.56
leiomyoblastoma cell line:G-402	10721-110A1	44.87	7.11
leiomyoma cell line:10964C	10569-108B2	65.38	16.88
leiomyoma cell line:15242A	10570-108B3	50.54	8.15
leiomyoma cell line:15425	10571-108B4	50.99	11.17
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	27.27	6.97
liposarcoma cell line:KMLS-1	10782-110G8	35.30	7.97
liposarcoma cell line:SW 872	10726-110A6	55.80	13.65
liver, adult, pool1	10018-101C9	16.37	2.43
liver, fetal, pool1	10086-102B5	49.86	5.64
locus coeruleus - adult, donor10196	10182-103D2	29.75	8.31
locus coeruleus, adult, donor10252	10165-103B3	33.59	7.01
locus coeruleus, adult, donor10258	10375-105G6	22.01	11.29
locus coeruleus, newborn, donor10223	10362-105F2	14.30	7.57
lung adenocarcinoma cell line:A549	10499-107C4	40.41	9.27
lung adenocarcinoma cell line:PC-14	10408-106B3	34.47	14.48
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	72.10	9.89
lung, adult, pool1	10019-101D1	53.04	8.98
lung, fetal, donor1	10068-101I5	53.09	15.98
lung, right lower lobe, adult, donor1	10075-102A3	65.52	19.25
lymph node, adult, donor1	10077-102A5	50.65	12.78
lymphangiectasia cell line:DS-1	10727-110A7	26.08	6.58
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	20.53	5.74
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	53.52	6.80
mature adipocyte, donor1	12231-129F8	42.62	7.55
mature adipocyte, donor2	12232-129F9	33.62	8.92
mature adipocyte, donor3	12233-129G1	28.92	8.30
mature adipocyte, donor4	12234-129G2	33.69	3.69
maxillary sinus tumor cell line:HSQ-89	10414-106B9	31.21	13.10
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	32.74	8.46
medial frontal gyrus, adult, donor10258	10368-105F8	30.18	12.39
medial frontal gyrus, newborn, donor10223	10352-105E1	14.93	11.94
medial temporal gyrus - adult, donor10196	10183-103D3	34.93	9.96
medial temporal gyrus, adult, donor10252	10156-103A3	42.23	9.97
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	19.26
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	28.00	13.64
medulla oblongata - adult, donor10196	10174-103C3	29.85	8.44
medulla oblongata, adult, donor10252	10155-103A2	40.40	6.50
medulla oblongata, adult, pool1	10038-101F2	29.30	11.84
medulla oblongata, newborn, donor10223	10361-105F1	28.47	10.76
medulloblastoma cell line:D283 Med	10838-111E1	12.40	6.86
medulloblastoma cell line:ONS-76	10759-110E3	30.81	10.27
melanoma cell line:COLO 679	10514-107E1	30.33	7.19
melanoma cell line:G-361	10465-106H6	22.53	9.23
meningioma cell line:HKBMM	10691-109F7	68.02	14.65
merkel cell carcinoma cell line:MKL-1	10843-111E6	27.32	16.74
merkel cell carcinoma cell line:MS-1	10844-111E7	19.18	10.89
mesenchymal precursor cell - adipose, donor1	11747-123G1	32.37	5.22
mesenchymal precursor cell - adipose, donor2	11748-123G2	21.27	4.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.60	7.45
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.96	7.59
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	40.44	5.20
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	53.44	6.94
mesenchymal precursor cell - cardiac, donor1	11752-123G6	30.72	5.66
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.27	6.56
mesenchymal precursor cell - cardiac, donor3	11754-123G8	24.14	7.16
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.17	5.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	40.69	6.40
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.40	7.25
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	25.32	7.06
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.72	6.63
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	30.01	5.72
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.02	10.42
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	24.72	6.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	45.37	10.26
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	35.24	5.03
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.63	7.62
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.65	9.10
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	46.02	6.63
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	38.92	13.45
mesenchymal stem cell line:Hu5/E18	10568-108B1	47.15	10.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	33.34	8.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.23	5.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	34.55	7.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.35	10.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	27.54	4.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	33.85	11.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	33.01	4.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	34.75	10.19
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	36.05	8.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.00	7.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.29	7.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	42.53	11.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	35.58	4.70
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	32.75	5.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	33.08	7.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	10.94
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	35.40	7.79
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	44.78	8.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	29.44	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	42.37	5.44
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	8.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	31.43	4.74
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	10.97
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	37.37	11.40
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.01	7.93
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	49.43	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	13.78
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.41	4.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	39.72	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.76	5.90
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	28.68	5.92
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	30.74	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	25.47	6.20
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.32	4.95
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	5.61
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.81	5.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	25.79	6.04
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	29.14	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	3.64
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	29.65	8.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	33.93	9.72
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.26	11.36
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	35.65	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	44.10	7.74
mesothelioma cell line:ACC-MESO-1	10493-107B7	83.16	22.68
mesothelioma cell line:ACC-MESO-4	10494-107B8	65.33	12.74
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	37.30	4.21
mesothelioma cell line:Mero-25	10850-111F4	55.15	8.62
mesothelioma cell line:Mero-41	10851-111F5	43.27	7.58
mesothelioma cell line:Mero-48a	10852-111F6	60.01	9.96
mesothelioma cell line:Mero-82	10853-111F7	49.14	8.15
mesothelioma cell line:Mero-83	10854-111F8	64.17	11.06
mesothelioma cell line:Mero-84	10855-111F9	29.83	7.33
mesothelioma cell line:Mero-95	10856-111G1	63.15	16.15
mesothelioma cell line:NCI-H2052	10847-111F1	50.52	8.94
mesothelioma cell line:NCI-H226	10846-111E9	54.30	5.07
mesothelioma cell line:NCI-H2452	10848-111F2	61.33	8.88
mesothelioma cell line:NCI-H28	10845-111E8	20.10	4.83
mesothelioma cell line:No36	10857-111G2	41.10	10.76
mesothelioma cell line:ONE58	10858-111G3	36.31	7.32
migratory langerhans cells, donor1	11901-125F2	90.01	18.81
migratory langerhans cells, donor2	11902-125F3	105.14	17.22
migratory langerhans cells, donor3	11903-125F4	77.54	17.95
mixed mullerian tumor cell line:HTMMT	10689-109F5	51.26	4.90
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	52.98	8.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	79.01	7.14
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.13	6.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	39.73	9.79
myeloma cell line:PCM6	10474-106I6	19.96	3.76
myxofibrosarcoma cell line:MFH-ino	10600-108E6	60.87	14.20
myxofibrosarcoma cell line:NMFH-1	10684-109E9	23.73	3.92
nasal epithelial cells, donor1, tech_rep1	12226-129F3	20.95	6.24
nasal epithelial cells, donor1, tech_rep2	12226-129F3	22.14	6.40
nasal epithelial cells, donor2	12227-129F4	24.84	4.97
neuroblastoma cell line:CHP-134	10508-107D4	15.64	5.06
neuroblastoma cell line:NB-1	10539-107G8	18.90	3.74
neuroblastoma cell line:NBsusSR	10607-108F4	23.83	5.90
neuroblastoma cell line:NH-12	10555-107I6	32.80	11.18
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	33.69	17.55
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	29.46	12.51
neuroectodermal tumor cell line:TASK1	10774-110F9	56.15	12.88
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.08	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	57.76	6.92
neutrophil PMN, donor1	12133-128D9	238.00	14.87
neutrophil PMN, donor2	12137-128E4	132.81	26.56
neutrophil PMN, donor3	12141-128E8	104.18	18.94
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	32.64	10.49
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.81	4.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.04	7.05
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	60.44	11.30
nucleus accumbens, adult, pool1	10037-101F1	29.72	12.19
occipital cortex - adult, donor10196	10172-103C1	30.91	4.12
occipital cortex, adult, donor10252	10163-103B1	44.28	9.12
occipital cortex, newborn, donor10223	10355-105E4	18.20	21.47
occipital lobe, adult, donor1	10076-102A4	30.70	17.58
occipital lobe, fetal, donor1	10073-102A1	39.91	13.73
occipital pole, adult, pool1	10036-101E9	27.04	11.35
olfactory region, adult	10195-103E6	22.93	11.08
optic nerve, donor1	10277-104E7	42.02	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	105.71	19.59
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	39.70	7.56
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	29.29	8.30
oral squamous cell carcinoma cell line:SAS	10544-107H4	19.64	4.50
osteoclastoma cell line:Hs 706.T	10704-109H2	68.49	7.94
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	24.29	8.41
osteosarcoma cell line:HS-Os-1	10558-107I9	41.14	7.63
ovary, adult, pool1	10020-101D2	28.13	7.69
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	45.65	6.05
pancreas, adult, donor1	10049-101G4	47.03	14.11
pancreatic carcinoma cell line:NOR-P1	10698-109G5	81.07	19.01
papillary adenocarcinoma cell line:8505C	10437-106E5	42.42	11.24
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.31	9.44
paracentral gyrus, adult, pool1	10035-101E8	28.37	11.62
parietal cortex, adult, donor10258	10373-105G4	15.41	11.01
parietal lobe - adult, donor10196	10171-103B9	31.04	8.46
parietal lobe, adult, donor10252	10157-103A4	36.77	9.12
parietal lobe, adult, pool1	10034-101E7	29.78	13.31
parietal lobe, fetal, donor1	10072-101I9	41.70	26.19
parietal lobe, newborn, donor10223	10356-105E5	28.79	17.20
parotid gland, adult	10199-103F1	17.88	4.32
penis, adult	10200-103F2	39.75	14.50
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	23.80	20.82
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	75.62	9.62
pineal gland - adult, donor10196	10179-103C8	21.93	4.52
pineal gland, adult, donor10252	10160-103A7	34.94	8.88
pineal gland, adult, donor10258	10377-105G8	19.44	11.29
pituitary gland - adult, donor10196	10180-103C9	35.41	4.05
pituitary gland, adult, donor10252	10162-103A9	54.20	9.90
pituitary gland, adult, donor10258	10378-105G9	28.09	11.92
placenta, adult, pool1	10021-101D3	41.50	10.75
plasma cell leukemia cell line:ARH-77	10840-111E3	16.55	3.31
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	27.08	7.47
pons, adult, pool1	10033-101E6	27.20	9.73
postcentral gyrus, adult, pool1	10032-101E5	29.99	13.77
promyelocytes/myelocytes PMC, donor1	12132-128D8	64.83	48.10
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	16.52
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00
prostate cancer cell line:DU145	10490-107B4	72.83	11.22
prostate cancer cell line:PC-3	10439-106E7	38.12	2.54
prostate, adult, pool1	10022-101D4	35.64	8.07
putamen, adult, donor10196	10176-103C5	29.27	9.44
putamen, adult, donor10252	10152-102I8	43.14	13.73
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	10.93
putamen, adult, donor10258, tech_rep2	10372-105G3	21.02	10.39
putamen, newborn, donor10223	10365-105F5	14.24	7.50
rectal cancer cell line:TT1TKB	10469-106I1	29.68	1.45
rectum, fetal, donor1	10067-101I4	107.11	22.26
renal cell carcinoma cell line:OS-RC-2	10411-106B6	71.23	12.30
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	29.41	7.87
retina, adult, pool1	10030-101E3	41.65	10.74
retinoblastoma cell line:Y79	10475-106I7	23.90	6.75
rhabdomyosarcoma cell line:KYM-1	10787-110H4	35.78	6.64
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.03	6.19
sacrococcigeal teratoma cell line:HTST	10695-109G2	59.87	12.88
salivary acinar cells, donor1	11771-123I7	32.86	5.83
salivary acinar cells, donor2	11772-123I8	32.49	7.85
salivary acinar cells, donor3	11773-123I9	37.74	9.93
salivary gland, adult, pool1	10093-102C3	21.73	13.73
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	51.77	16.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.32	13.99
seminal vesicle, adult	10201-103F3	34.92	9.52
serous adenocarcinoma cell line:JHOS-2	10639-108I9	35.71	7.77
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.19	6.29
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	9.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	186.97	16.39
signet ring carcinoma cell line:Kato III	10436-106E4	32.72	6.96
signet ring carcinoma cell line:NUGC-4	10483-107A6	55.09	8.26
skeletal muscle - soleus muscle, donor1	10282-104F3	31.92	10.64
skeletal muscle, adult, pool1	10023-101D5	38.38	8.76
skeletal muscle, fetal, donor1	10066-101I3	34.17	14.07
skin, adult, donor1	10074-102A2	47.50	13.57
skin, fetal, donor1	10065-101I2	35.35	13.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	33.35	6.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	15.13	5.99
small cell lung carcinoma cell line:DMS 144	10841-111E4	38.55	29.30
small cell lung carcinoma cell line:LK-2	10541-107H1	20.93	8.74
small cell lung carcinoma cell line:NCI-H82	10842-111E5	18.66	9.49
small cell lung carcinoma cell line:WA-hT	10562-108A4	14.82	3.05
small intestine, adult, pool1	10024-101D6	58.89	12.78
small intestine, fetal, donor1	10064-101I1	38.82	13.76
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.65	7.18
smooth muscle, adult, pool1	10048-101G3	48.59	11.63
somatostatinoma cell line:QGP-1	10781-110G7	30.29	5.63
spinal cord - adult, donor10196	10181-103D1	39.00	9.18
spinal cord, adult, donor10252	10159-103A6	28.78	7.10
spinal cord, adult, donor10258	10369-105F9	13.84	15.91
spinal cord, fetal, donor1	10056-101H2	60.98	20.12
spinal cord, newborn, donor10223	10359-105E8	19.29	8.27
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	59.29	10.75
spleen, adult, pool1	10025-101D7	37.34	6.94
spleen, fetal, pool1	10044-101F8	41.71	9.61
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.94	4.97
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.35	9.11
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	37.74	12.93
squamous cell carcinoma cell line:T3M-5	10616-108G4	76.23	11.34
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	88.92	20.82
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.23	8.47
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	66.00	8.88
stomach, fetal, donor1	10062-101H8	75.83	17.09
submaxillary gland, adult	10202-103F4	36.46	11.39
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	38.43	5.82
substantia nigra, adult, donor10258	10371-105G2	15.00	17.59
substantia nigra, newborn, donor10223	10358-105E7	34.62	12.72
synovial sarcoma cell line:HS-SY-II	10441-106E9	58.00	15.59
temporal lobe, adult, pool1	10031-101E4	30.86	13.99
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	41.31	17.09
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	34.28	18.02
tenocyte, donor1	11763-123H8	35.26	7.33
tenocyte, donor2	11765-123I1	66.00	13.73
tenocyte, donor3	11768-123I4	43.37	8.53
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	60.85	19.72
teratocarcinoma cell line:NCR-G1	10798-110I6	43.47	14.18
teratocarcinoma cell line:PA-1	10807-111A6	66.18	14.57
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	44.43	15.36
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	60.89	21.18
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	26.17	9.71
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	55.04	8.79
testis, adult, pool1	10026-101D8	31.35	9.02
testis, adult, pool2	10096-102C6	47.82	21.20
thalamus - adult, donor10196	10168-103B6	36.43	8.83
thalamus, adult, donor10252	10154-103A1	34.85	7.35
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	20.02
thalamus, adult, donor10258, tech_rep2	10370-105G1	17.79	6.92
thalamus, newborn, donor10223	10366-105F6	20.71	12.08
throat, adult	10209-103G2	47.94	13.73
throat, fetal, donor1	10061-101H7	45.10	12.19
thymic carcinoma cell line:Ty-82	10803-111A2	55.45	15.90
thymus, adult, pool1	10027-101D9	27.64	11.73
thymus, fetal, pool1	10043-101F7	43.22	11.74
thyroid carcinoma cell line:KHM-5M	10776-110G2	84.70	15.42
thyroid carcinoma cell line:TCO-1	10783-110G9	49.31	11.73
thyroid, adult, pool1	10028-101E1	35.27	7.56
thyroid, fetal, donor1	10060-101H6	48.25	10.02
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	9.24
tongue, adult	10203-103F5	41.40	9.54
tongue, fetal, donor1	10059-101H5	56.75	17.34
tonsil, adult, pool1	10047-101G2	39.97	11.82
trachea, adult, pool1	10029-101E2	32.07	6.87
trachea, fetal, donor1	10058-101H4	48.86	10.39
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	61.64	16.65
transitional-cell carcinoma cell line:5637	10418-106C4	24.72	5.37
transitional-cell carcinoma cell line:JMSU1	10492-107B6	80.54	14.26
tridermal teratoma cell line:HGRT	10694-109G1	39.95	13.32
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	52.57	13.63
umbilical cord, fetal, donor1	10057-101H3	35.47	18.78
uterus, adult, pool1	10100-102D1	41.46	20.65
uterus, fetal, donor1	10055-101H1	50.17	9.21
vagina, adult	10204-103F6	47.17	9.69
vein, adult	10191-103E2	44.94	9.64
xeroderma pigentosum b cell line:XPL 17	10563-108A5	17.62	5.34